The latest market report published by Credence Research, Inc. Global Small Animals Respiratory Diseases Treatment Market - Growth, Share, Opportunities, Pipeline Analysis, Competitive Analysis, and Forecast, 2016 - 2024, the small animals respiratory diseases treatment market was valued at USD 18,350.2 Mn in 2015, and is expected to reach USD 23,064.0 Mn by 2024, expanding at a CAGR of 2.5% from 2016 to 2024.

Browse the full report Small Animals Respiratory Diseases Treatment Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 2024 at http://www.credenceresearch.com/report/small-animal-respiratory-diseases-treatment-market

Market Insights

According to veterinary health experts, symptoms and diseases related with respiratory infection are frequent during the first of year life in small animals. These respiratory infections are usually caused by bacteria and virus transferred through an environmental media. The Banfield Pet Hospital suggested that in the U.S obesity in pets is increasing swiftly these days around 37% of dogs analyzed were overweight and around 90% of cats analyzed were obese. Thus, obesity is one of the prominent causes of respiratory diseases and other chronic disorders in small animals.

The market segmentation of small animal respiratory diseases treatment comprises type of diseases and drug class. According to market experts, allergic pneumonitis, canine influenza, rhinitis and sinusitis and tonsillitis were observed as the most common respiratory diseases observed in small animals. The most common symptoms observed in small animals such as coughing or dyspnoea with common disorders such as brachycephalic syndrome, laryngeal paralysis, tracheal collapse, and feline asthma syndrome According to American Veterinary Medical Foundation, the first recognized U.S. outbreak of H3N2 canine influenza occurred in 2015, starting in Chicago and spreading to other Midwestern states. Since March 2015, outbreaks have occurred in a number of areas throughout the U.S. and thousands of dogs have been confirmed positive for the H3N2 virus. It was observed that prevalence of canine influenza was also observed in cats and the displayed signs of upper respiratory disease including discharge, congestion, malaise, lip smacking and excessive salivation. In 2015, it was observed that anthelmintics, corticosteroids and antibiotics accounted for more than 50% market share of the overall small animal respiratory diseases treatment market. According to market experts, most anthelmintics have wide safety margins, i.e., the dosage that can be given to an animal before adverse effects are induced is much higher than the dosage recommended for use.

North America was observed as the largest market for small animal respiratory diseases treatment market due to factors such as rising air pollution, lack of sanitation related to pets in a few households, increasing urban trend of having dogs and cats as pets and rising awareness associated with the well-being of small animals.

Key Market Movements:

• Rising air pollution accompanied with increasing obesity issues in pets
• Lack of sanitization associated with pets and increasing urban trend of having dogs and cats as pets
• There is a noticeable inclination towards pet humanization, especially among young, urban and affluent consumers, and is expected to trade up to mid-priced or premium products

Browse the full report Small Animals Respiratory Diseases Treatment Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 2024 at http://www.credenceresearch.com/report/small-animal-respiratory-diseases-treatment-market

Respiratory disease is a medical term that encompasses pathological conditions affecting the organs and tissues that make gas exchange possible in higher organisms, and includes conditions of the upper respiratory tract, trachea, bronchi, bronchioles, alveoli, pleura and pleural cavity, and the nerves and muscles of breathing. Respiratory diseases range from mild and self-limiting, such as the common cold, to life-threatening entities like bacterial pneumonia, pulmonary embolism, acute asthma and lung cancer.The study of respiratory disease is known as pulmonology. A doctor who specializes in respiratory disease is known as a pulmonologist, a chest medicine specialist, a respiratory medicine specialist, a respirologist or a thoracic medicine specialist.

Respiratory diseases can be classified in many different ways, including by the organ or tissue involved, by the type and pattern of associated signs and symptoms, or by the cause of the disease.Chronic respiratory diseases (CRDs) are diseases of the airways and other structures of the lung. They are characterized by a high inflammatory cell recruitment (neutrophil) and/or destructive cycle of infection, (e.g. mediated by Pseudomonas aeruginosa). Some of the most common are asthma, chronic obstructive pulmonary disease, and acute respiratory distress syndrome. CRDs are not curable; however, various forms of treatment that help dilate major air passages and improve shortness of breath can help control symptoms and increase the quality of life for people with the diseases. Source: Wikipedia

 Latest Reports:

Healthcare Tele-Consultation Services Market: http://www.credenceresearch.com/press/global-healthcare-tele-consultation-services-market

Blog: https://globenewswire.com/news-release/2018/03/08/1418682/0/en/Custom-T-shirt-Printing-Market-is-Expected-To-Cross-US-10-Billion-by-2025-Credence-Research.html

About:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared for this task.

Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph: 1-800-361-8290
Web: http://www.credenceresearch.com